DK0840735T3 - Spaltning af 1-azabicyclo[2.2.2]octan-3-amin, 2-(diphenylmethyl)-N-2-methoxy-5-(1methylethyl)phenyl]methyl] - Google Patents
Spaltning af 1-azabicyclo[2.2.2]octan-3-amin, 2-(diphenylmethyl)-N-2-methoxy-5-(1methylethyl)phenyl]methyl]Info
- Publication number
- DK0840735T3 DK0840735T3 DK96918801T DK96918801T DK0840735T3 DK 0840735 T3 DK0840735 T3 DK 0840735T3 DK 96918801 T DK96918801 T DK 96918801T DK 96918801 T DK96918801 T DK 96918801T DK 0840735 T3 DK0840735 T3 DK 0840735T3
- Authority
- DK
- Denmark
- Prior art keywords
- diphenylmethyl
- azabicyclo
- octane
- cleavage
- methoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US119195P | 1995-07-17 | 1995-07-17 | |
| PCT/IB1996/000648 WO1997003984A1 (en) | 1995-07-17 | 1996-07-04 | Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl] |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0840735T3 true DK0840735T3 (da) | 2004-02-09 |
Family
ID=21694832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96918801T DK0840735T3 (da) | 1995-07-17 | 1996-07-04 | Spaltning af 1-azabicyclo[2.2.2]octan-3-amin, 2-(diphenylmethyl)-N-2-methoxy-5-(1methylethyl)phenyl]methyl] |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6008357A (da) |
| EP (1) | EP0840735B1 (da) |
| JP (1) | JP3043074B2 (da) |
| KR (1) | KR100276989B1 (da) |
| CN (1) | CN1068598C (da) |
| AR (1) | AR002772A1 (da) |
| AT (1) | ATE250600T1 (da) |
| AU (1) | AU697553B2 (da) |
| CA (1) | CA2227194C (da) |
| CO (1) | CO4480720A1 (da) |
| CZ (1) | CZ15098A3 (da) |
| DE (1) | DE69630123T2 (da) |
| DK (1) | DK0840735T3 (da) |
| ES (1) | ES2205039T3 (da) |
| HK (1) | HK1010195A1 (da) |
| HU (1) | HUP9900238A3 (da) |
| IL (1) | IL122655A0 (da) |
| MY (1) | MY115734A (da) |
| NO (1) | NO980211L (da) |
| NZ (1) | NZ310539A (da) |
| PE (1) | PE8798A1 (da) |
| PL (1) | PL184261B1 (da) |
| PT (1) | PT840735E (da) |
| RU (1) | RU2136681C1 (da) |
| WO (1) | WO1997003984A1 (da) |
| ZA (1) | ZA966026B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6861526B2 (en) | 2002-10-16 | 2005-03-01 | Pfizer Inc. | Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine |
| RU2320659C9 (ru) * | 2004-02-02 | 2008-07-20 | Пфайзер Продактс Инк. | Способы получения 1-(2s, 3s)-2-бензгидрил-n-(5-трет-бутил-2-метоксибензил)хинуклидин-3-амина в виде камфорсульфатной соли, цитратной соли и свободного основания и промежуточное соединение |
| EP1812391A2 (en) * | 2004-11-10 | 2007-08-01 | Boehringer Ingelheim Chemicals, Inc. | Process of making fentanyl intermediates |
| AU2009324679A1 (en) * | 2008-12-09 | 2011-07-28 | University Of Florida Research Foundation, Inc. | Kinase inhibitor compounds |
| US20160332962A1 (en) | 2015-05-13 | 2016-11-17 | Janssen Pharmaceutica Nv | (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine |
| CN108341812A (zh) * | 2017-01-23 | 2018-07-31 | 科贝源(北京)生物医药科技有限公司 | 一种含奎宁环化合物的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX18467A (es) * | 1988-11-23 | 1993-07-01 | Pfizer | Agentes terapeuticos de quinuclidinas |
| NO168529C (no) * | 1989-09-15 | 1992-03-04 | Chiron Lab As | Fremgangsmaate for fremstilling av s-(-) og r-(+)-n-(quinuclidinyl-3)-amider. |
| DK0585328T3 (da) * | 1991-05-22 | 2002-02-11 | Pfizer | Substituerede 3-aminoquinuclidiner |
| JPH0733386B2 (ja) * | 1991-05-31 | 1995-04-12 | フアイザー・インコーポレイテツド | キヌクリジン誘導体 |
| US5604241A (en) * | 1992-10-21 | 1997-02-18 | Pfizer Inc. | Substituted benzylaminoquinuclidines as substance P antagonists |
-
1996
- 1996-07-03 PE PE1996000507A patent/PE8798A1/es not_active Application Discontinuation
- 1996-07-04 NZ NZ310539A patent/NZ310539A/en unknown
- 1996-07-04 DK DK96918801T patent/DK0840735T3/da active
- 1996-07-04 HU HU9900238A patent/HUP9900238A3/hu unknown
- 1996-07-04 CA CA002227194A patent/CA2227194C/en not_active Expired - Fee Related
- 1996-07-04 JP JP9506471A patent/JP3043074B2/ja not_active Expired - Fee Related
- 1996-07-04 RU RU98101101A patent/RU2136681C1/ru not_active IP Right Cessation
- 1996-07-04 CN CN96195567A patent/CN1068598C/zh not_active Expired - Fee Related
- 1996-07-04 EP EP96918801A patent/EP0840735B1/en not_active Expired - Lifetime
- 1996-07-04 AT AT96918801T patent/ATE250600T1/de not_active IP Right Cessation
- 1996-07-04 CZ CZ98150A patent/CZ15098A3/cs unknown
- 1996-07-04 KR KR1019980700362A patent/KR100276989B1/ko not_active IP Right Cessation
- 1996-07-04 IL IL12265596A patent/IL122655A0/xx unknown
- 1996-07-04 PT PT96918801T patent/PT840735E/pt unknown
- 1996-07-04 WO PCT/IB1996/000648 patent/WO1997003984A1/en not_active Application Discontinuation
- 1996-07-04 PL PL96324610A patent/PL184261B1/pl not_active IP Right Cessation
- 1996-07-04 US US08/981,750 patent/US6008357A/en not_active Expired - Fee Related
- 1996-07-04 AU AU61348/96A patent/AU697553B2/en not_active Ceased
- 1996-07-04 DE DE69630123T patent/DE69630123T2/de not_active Expired - Fee Related
- 1996-07-04 ES ES96918801T patent/ES2205039T3/es not_active Expired - Lifetime
- 1996-07-05 AR ARP960103482A patent/AR002772A1/es not_active Application Discontinuation
- 1996-07-15 CO CO96037152A patent/CO4480720A1/es unknown
- 1996-07-16 ZA ZA9606026A patent/ZA966026B/xx unknown
- 1996-07-17 MY MYPI96002939A patent/MY115734A/en unknown
-
1998
- 1998-01-16 NO NO980211A patent/NO980211L/no not_active Application Discontinuation
- 1998-10-13 HK HK98111206A patent/HK1010195A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9611436A (pt) | D-tartarato de (-)-cis-6(s)-fenil-5(r)-[4-(2-pirrolidin-1-iletóxi) fenil]-5,6,7,8,-tetra-hidronaftalen-2-ol | |
| CY2007024I1 (el) | Kαινοφανη παραγωγα 3.3-διαφαινυλοπροπυλινων | |
| PT907650E (pt) | N-¬4-(heteroarilmetil)fenil|heteroarilaminasc | |
| FI972970A0 (fi) | Uusia yhdisteitä | |
| ID20053A (id) | Hipolipidemat 1,4-benzotiazepin-1,1-dioksida | |
| FI20030370A (fi) | Uusia yhdisteitä | |
| MX206776B (es) | Compuestos no tejidos hidroenredados. | |
| ID17053A (id) | Derivat-derivat 2-(2-okso-etiliden)-imidazolidin-4-on | |
| PT1000048E (pt) | Derivados substituidos do 1,2,3,4-tetrahidronaftaleno | |
| CY2004003I2 (el) | Παραγωγα 2-(2-αμινο-1, 6-διϋδρο-6-οξο-πυρινο-9-υλο)-μεθοδυ-1,3-προπανεδιολης | |
| DK0820451T3 (da) | Hidtil ukendte heterocykliske forbindelser | |
| DK0754407T3 (da) | Flydende formuleringer af 1,2-benzisothiazolin-3-on | |
| FI971674A0 (fi) | Heterosyklisen ryhmän sisältämät di-tert-butyyli-fenoliyhdisteet, käyttökelpoisia tulehduksenvastaisina aineina | |
| DK0927173T3 (da) | Substituerede [2-(1-piperazinyl)ethoxy]methylforbindelser | |
| MA23779A1 (fr) | Compose 9-substitue 2-(2-n-alkoxyphenyl) - purine -6- ones | |
| TR199600137A2 (tr) | Bitümlü bilesimler. | |
| IT1302243B1 (it) | Sintesi dell'1,1,1,3,3-pentafluoropropano. | |
| ES1031452Y (es) | Nueva canica mejorada. | |
| FI942971A0 (fi) | Foerfarande foer vaexling av signalkaelle i mottagaren i ett digitalt universalsaendningssystem, samt mottagare foer digitalt universalsaendningssystem | |
| DK0840735T3 (da) | Spaltning af 1-azabicyclo[2.2.2]octan-3-amin, 2-(diphenylmethyl)-N-2-methoxy-5-(1methylethyl)phenyl]methyl] | |
| DK0815092T3 (da) | Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner | |
| ES1031116Y (es) | Barredora perfeccionada. | |
| DK0810216T3 (da) | Derivater af 10,11-dihydro-10-oxo-5H-dibenz/b/,f/azepin-5-carboxamid | |
| NO973624D0 (no) | Vasokonstriktive substituerte 2,3-dihydro-1,4-dioksinopiperidiner | |
| ID16434A (id) | Senyawa-senyawa 1,4-dihidropiridin |